Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
The delivery of cancer care in Nigeria is impeded firstly by a lack of infrastructure, with a low number of hospital beds and skilled staff across the care pathway—an issue which has been compounded by the migration of skilled staff out of sub-Saharan Africa and to more developed countries. A lack of specialized equipment, such as radiotherapy machines, and the prohibitive costs of delivering cancer care are significant challenges as well. According to Dr. Modupe Elebute-Odunsi, challenges at the governmental level play a role as well, because in addition to a lack of skilled staff, there is a lack of developed cancer centers and a lack of funding, all of which prevent patients from accessing high-quality care. This great need inspired Dr. Elebute-Odunsi to establish the Marcelle Ruth Cancer Centre and Specialist Hospital in Lagos, Nigeria, which offers all the treatments patients need across the care continuum in one place.
“We’re a one-stop comprehensive cancer center...When patients walk in the door, they can [receive] all the treatments they require [here] from beginning to end.”
Read more global perspectives from the international panelists who spoke at the October ACCC 41st National Oncology Conference in this ACCCBuzz blog.
Guests:
Modupe Elebute-Odunsi, MBBS, MD, FRCP, FRCPath
Founder/CEO
Marcelle Ruth Cancer Centre and Specialist Hospital
Founder/Chair Board of Trustees
Women In Healthcare Network
Lagos, Nigeria
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
